Inhibition of foam cell formation using a soluble CD68-Fc fusion protein

Journal of Molecular Medicine

Volumn 88, Issue 9, 2010, Pages 909-920

  Daub, Karin ^a   Siegel Axel, Dorothea ^a   Schönberger, Tanja ^a   Leder, Christoph ^a   Seizer, Peter ^a   Müller, Karin ^a   Schaller, Martin ^b   Penz, Sandra ^c   Menzel, Dagmar ^a   Büchele, Berthold ^d   Bültmann, Andreas ^e   Münch, Götz ^e   Lindemann, Stephan ^a   Simmet, Thomas ^d   Gawaz, Meinrad ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF ULM   (Germany)

^e NONE   (Germany)

Author keywords

Atherosclerosis; Foam cells; Lipoproteins; Macrophages; Platelets

Indexed keywords

APOLIPOPROTEIN E; CD68 ANTIGEN FC RECEPTOR FUSION PROTEIN; HYBRID PROTEIN; METALLOPROTEINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BINDING AFFINITY; CLONE; CONTROLLED STUDY; DRUG MECHANISM; FOAM CELL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN BINDING;

EID: 77956420059     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-010-0629-y     Document Type: Article

References (38)

1. L Badimon J Martinez-Gonzalez V Llorente-Cortes C Rodriguez T Padro 2006 Cell biology and lipoproteins in atherosclerosis Curr Mol Med 6 439 456 10.2174/156652406778018725 1:CAS:528:DC%2BD28XnslOnt7w%3D 16918367
2. G Stoll M Bendszus 2006 Inflammation and atherosclerosis: novel insights into plaque formation and destabilization Stroke 37 1923 1932 10.1161/01.STR.0000226901.34927.10 1:CAS:528:DC%2BD28XmtVShu7c%3D 16741184
3. KJ Moore MW Freeman 2006 Scavenger receptors in atherosclerosis: beyond lipid uptake Arterioscler Thromb Vasc Biol 26 1702 1711 10.1161/01.ATV. 0000229218.97976.43 1:CAS:528:DC%2BD28XmvFaksLY%3D 16728653
4. MS Brown JL Goldstein 1983 Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis Annu Rev Biochem 52 223 261 10.1146/annurev.bi.52.070183.001255 1:CAS:528:DyaL3sXltVaqur8%3D 6311077
5. PJ Gough S Gordon DR Greaves 2001 The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo Immunology 103 351 361 10.1046/j.1365-2567.2001.01256.x 1:CAS:528:DC%2BD3MXltlaqs78%3D 11454064
6. E Falk 2006 Pathogenesis of atherosclerosis J Am Coll Cardiol 47 C7 12 10.1016/j.jacc.2005.09.068 1:CAS:528:DC%2BD28XksVKmtrs%3D 16631513
7. MP Ramprasad V Terpstra N Kondratenko O Quehenberger D Steinberg 1996 Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein Proc Natl Acad Sci USA 93 14833 14838 10.1073/pnas.93.25.14833 1:CAS:528:DyaK28XnsVOlsr0%3D 8962141
8. DR Greaves S Gordon 2005 Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors J Lipid Res 46 11 20 10.1194/jlr.R400011-JLR200 1:CAS:528: DC%2BD2MXltlKrsw%3D%3D 15548472
9. AC Li CK Glass 2002 The macrophage foam cell as a target for therapeutic intervention Nat Med 8 1235 1242 10.1038/nm1102-1235 1:CAS:528: DC%2BD38XotlWmu7w%3D 12411950
10. G Llaverias A Rebollo J Pou M Vazquez-Carrera RM Sanchez JC Laguna M Alegret 2006 Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes Biochem Pharmacol 71 605 614 10.1016/j.bcp.2005.11.022 1:CAS:528:DC%2BD28XosFKmug%3D%3D 16386711
11. J Han X Zhou T Yokoyama DP Hajjar AM Gotto Jr AC Nicholson 2004 Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36 Circulation 109 790 796 10.1161/01.CIR.0000112576.40815.13 1:CAS:528:DC%2BD2cXhtFWltb4%3D 14970117
12. TJ Van Berkel R Out M Hoekstra J Kuiper E Biessen M Van Eck 2005 Scavenger receptors: friend or foe in atherosclerosis? Curr Opin Lipidol 16 525 535 10.1097/01.mol.0000183943.20277.26 16148537
13. B Fuhrman L Koren N Volkova S Keidar T Hayek M Aviram 2002 Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes Atherosclerosis 164 179 185 10.1016/S0021-9150(02)00063-1 1:CAS:528:DC%2BD38Xlt12lt7c%3D 12119208
14. F Bruni AL Pasqui M Pastorelli G Bova M Cercignani A Palazzuoli T Sawamura WR Gioffre A Auteri L Puccetti 2005 Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects Clin Appl Thromb Hemost 11 417 428 10.1177/107602960501100408 1:CAS:528:DC%2BD2MXht1elur3N 16244767
15. H Bays 2006 Statin safety: an overview and assessment of the data-2005 Am J Cardiol 97 6C 26C 10.1016/j.amjcard.2005.12.006 1:CAS:528: DC%2BD28XkvF2hu70%3D 16581330
16. S Massberg I Konrad A Bültmann C Schulz G Münch M Peluso M Lorenz S Schneider F Besta I Müller B Hu H Langer E Kremmer M Rudelius U Heinzmann M Ungerer M Gawaz 2004 Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo FASEB J 18 397 399 1:CAS:528:DC%2BD2cXht1GjtLg%3D 14656994
17. + progenitor cells into foam cells and endothelial cells FASEB J 20 2559 2561 10.1096/fj.06-6265fje 1:CAS:528:DC%2BD28Xht1yms7fF 17077283
18. R Schmidt A Bültmann M Ungerer N Joghetaei O Bulbul S Thieme T Chavakis BP Toole M Gawaz A Schömig AE May 2006 Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction Circulation 113 834 841 10.1161/CIRCULATIONAHA.105.568162 1:CAS:528:DC%2BD28XhtFeis7c%3D 16461815
19. DI Axel A Frigge J Dittmann H Runge I Spyridopoulos R Riessen R Viebahn KR Karsch 2001 All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells Cardiovasc Res 49 851 862 10.1016/S0008-6363(00)00312-6 1:CAS:528:DC%2BD3MXhsVOiurY%3D 11230985
20. -/- mice Cardiovasc Res 80 131 137 10.1093/cvr/cvn169 18566102
21. C Schulz S Penz C Hoffmann H Langer A Gillitzer S Schneider R Brandl S Seidl S Massberg B Pichler E Kremmer K Stellos T Schönberger W Siess M Gawaz 2008 Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo Basic Res Cardiol 103 356 367 10.1007/s00395-008-0722-3 1:CAS:528:DC%2BD1cXptVWju78%3D 18431526
22. HB Brewer Jr 2000 The lipid-laden foam cell: an elusive target for therapeutic intervention J. Clin. Invest 105 703 705 10.1172/JCI9664 1:CAS:528:DC%2BD3cXhvFehsL0%3D 10727436
23. OH Brekke I Sandlie 2003 Therapeutic antibodies for human diseases at the dawn of the twenty-first century Nat Rev Drug Discov 2 52 62 10.1038/nrd984 1:CAS:528:DC%2BD3sXntF0%3D 12509759
24. RP Choudhury JM Lee DR Greaves 2005 Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis Nat Clin Pract Cardiovasc Med 2 309 315 10.1038/ncpcardio0195 1:CAS:528:DC%2BD2MXlsFOgs70%3D 16265535
25. LH Stockwin S Holmes 2003 The role of therapeutic antibodies in drug discovery Biochem Soc Trans 31 433 436 10.1042/BST0310433 1:CAS:528: DC%2BD3sXisFGjt7g%3D 12653655
26. R Oksjoki PT Kovanen KA Lindstedt B Jansson MO Pentikainen 2006 OxLDL-IgG immune complexes induce survival of human monocytes Arterioscler Thromb Vasc Biol 26 576 583 10.1161/01.ATV.0000201041.14438.8d 1:CAS:528: DC%2BD28XisFartL8%3D 16373614
27. RL Griffith GT Virella HC Stevenson MF Lopes-Virella 1988 Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation J Exp Med 168 1041 1059 10.1084/jem.168.3.1041 1:CAS:528:DyaL1cXlvVymtLs%3D 3171477
28. ZY Yuan Y Liu C Kishimoto K Shioji M Yokode ZQ Liu 2003 The Fc region of immunoglobulin suppresses atherosclerosis in apolipoprotein E knockout mice Zhonghua Yi Xue Za Zhi 83 489 493 1:CAS:528:DC%2BD3sXnsVensLg%3D 12887764
29. A Nicoletti G Paulsson G Caligiuri X Zhou GK Hansson 2000 Induction of neonatal tolerance to oxidized lipoprotein reduces atherosclerosis in ApoE knockout mice Mol Med 6 283 290 1:CAS:528:DC%2BD3cXlsFWjsrg%3D 10949909
30. Y Miura T Takahashi SM Jung M Moroi 2002 Analysis of the interaction of platelet collagen receptor glycoprotein VI (GPVI) with collagen. A dimeric form of GPVI, but not the monomeric form, shows affinity to fibrous collagen J Biol Chem 277 46197 46204 10.1074/jbc.M204029200 1:CAS:528:DC%2BD38XovFKhsro%3D 12356768
31. A Ashkenazi SM Chamow 1997 Immunoadhesins as research tools and therapeutic agents Curr Opin Immunol 9 195 200 10.1016/S0952-7915(97)80135-5 1:CAS:528:DyaK2sXivFWjsrw%3D 9099788
32. RL Yung 2001 Etanercept Immunex Curr Opin Investig Drugs 2 216 221 1:CAS:528:DC%2BD3MXhs1Sksb8%3D 11816834
33. MC de Beer Z Zhao NR Webb DR van der Westhuyzen WJ de Villiers 2003 Lack of a direct role for macrosialin in oxidized LDL metabolism J Lipid Res 44 674 685 10.1194/jlr.M200444-JLR200 12562841
34. M Rouis 2005 Matrix metalloproteinases: a potential therapeutic target in atherosclerosis Curr Drug Targets Cardiovasc Haematol Disord 5 541 548 10.2174/156800605774961979 1:CAS:528:DC%2BD28XitlyksQ%3D%3D 16503874
35. J Laukkanen P Lehtolainen PJ Gough DR Greaves S Gordon S Yla-Herttuala 2000 Adenovirus-mediated gene transfer of a secreted form of human macrophage scavenger receptor inhibits modified low-density lipoprotein degradation and foam-cell formation in macrophages Circulation 101 1091 1096 1:CAS:528:DC%2BD3cXit1aks7s%3D 10715253
36. J Jalkanen P Leppanen O Narvanen DR Greaves S Yla-Herttuala 2003 Adenovirus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor (SR-AI) in LDL receptor knock-out mice Atherosclerosis 169 95 103 10.1016/S0021-9150(03)00155-2 1:CAS:528:DC%2BD3sXlt1Wnu7o%3D 12860255
37. SJ Levine 2004 Mechanisms of soluble cytokine receptor generation J Immunol 173 5343 5348 1:CAS:528:DC%2BD2cXos1Gitbg%3D 15494479
38. S Rose-John PC Heinrich 1994 Soluble receptors for cytokines and growth factors: generation and biological function Biochem J 300 Pt 2 281 290 1:CAS:528:DyaK2cXktlalsLw%3D 8002928